ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

Sequential Administration of WJ-MSCs for the Treatment of GvHD Refractory to Second Line Treatment

Fundación Oftalmológica de Santander Clínica Carlos Ardila Lulle · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
mesenchymal-stem-cells
graft versus host disease, graft-versus-host disease, ruxolitinib, mesenchymal stem cells, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833782
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.